255 related articles for article (PubMed ID: 31940630)
1. Statins Directly Regulate Pituitary Cell Function and Exert Antitumor Effects in Pituitary Tumors.
Vázquez-Borrego MC; Fuentes-Fayos AC; Herrera-Martínez AD; Venegas-Moreno E; L-López F; Fanciulli A; Moreno-Moreno P; Alhambra-Expósito MR; Barrera-Martín A; Dios E; Blanco-Acevedo C; Solivera J; Granata R; Kineman RD; Gahete MD; Soto-Moreno A; Gálvez-Moreno MA; Castaño JP; Luque RM
Neuroendocrinology; 2020; 110(11-12):1028-1041. PubMed ID: 31940630
[TBL] [Abstract][Full Text] [Related]
2. Biguanides Exert Antitumoral Actions in Pituitary Tumor Cells Through AMPK-Dependent and -Independent Mechanisms.
Vázquez-Borrego MC; Fuentes-Fayos AC; Herrera-Martínez AD; L-López F; Ibáñez-Costa A; Moreno-Moreno P; Alhambra-Expósito MR; Barrera-Martín A; Blanco-Acevedo C; Dios E; Venegas-Moreno E; Solivera J; Gahete MD; Soto-Moreno A; Gálvez-Moreno MA; Castaño JP; Luque RM
J Clin Endocrinol Metab; 2019 Aug; 104(8):3501-3513. PubMed ID: 30860580
[TBL] [Abstract][Full Text] [Related]
3. A New Generation Somatostatin-Dopamine Analogue Exerts Potent Antitumoral Actions on Pituitary Neuroendocrine Tumor Cells.
Vázquez-Borrego MC; L-López F; Gálvez-Moreno MA; Fuentes-Fayos AC; Venegas-Moreno E; Herrera-Martínez AD; Blanco-Acevedo C; Solivera J; Landsman T; Gahete MD; Soto-Moreno A; Culler MD; Castaño JP; Luque RM
Neuroendocrinology; 2020; 110(1-2):70-82. PubMed ID: 31272096
[TBL] [Abstract][Full Text] [Related]
4. A Somatostatin Receptor Subtype-3 (SST
Vázquez-Borrego MC; Gupta V; Ibáñez-Costa A; Gahete MD; Venegas-Moreno E; Toledano-Delgado Á; Cano DA; Blanco-Acevedo C; Ortega-Salas R; Japón MA; Barrera-Martín A; Vasiljevic A; Hill J; Zhang S; Halem H; Solivera J; Raverot G; Gálvez MA; Soto-Moreno A; Paez-Pereda M; Culler MD; Castaño JP; Luque RM
Clin Cancer Res; 2020 Feb; 26(4):957-969. PubMed ID: 31624102
[TBL] [Abstract][Full Text] [Related]
5. The Pituitary Gland is a Novel Major Site of Action of Metformin in Non-Human Primates: a Potential Path to Expand and Integrate Its Metabolic Actions.
Vázquez-Borrego MC; Fuentes-Fayos AC; Gahete MD; Castaño JP; Kineman RD; Luque RM
Cell Physiol Biochem; 2018; 49(4):1444-1459. PubMed ID: 30205369
[TBL] [Abstract][Full Text] [Related]
6. Disulfiram mediated anti-tumour effect in pituitary neuroendocrine tumours by inducing cuproptosis.
Huang N; Feng Y; Liu Y; Zhang Y; Liu L; Zhang B; Zhang T; Su Z; Xue L; Wu ZB
Int Immunopharmacol; 2024 Jun; 134():112159. PubMed ID: 38692018
[TBL] [Abstract][Full Text] [Related]
7. Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?
Herrera-Martínez AD; Pedraza-Arevalo S; L-López F; Gahete MD; Gálvez-Moreno MA; Castaño JP; Luque RM
J Clin Endocrinol Metab; 2019 Jan; 104(1):57-73. PubMed ID: 30265346
[TBL] [Abstract][Full Text] [Related]
8. Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features.
Vázquez-Borrego MC; Fuentes-Fayos AC; Venegas-Moreno E; Rivero-Cortés E; Dios E; Moreno-Moreno P; Madrazo-Atutxa A; Remón P; Solivera J; Wildemberg LE; Kasuki L; López-Fernández JM; Gadelha MR; Gálvez-Moreno MA; Soto-Moreno A; Gahete MD; Castaño JP; Luque RM
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31561558
[TBL] [Abstract][Full Text] [Related]
9. [Medical Therapies in Functioning Pituitary Neuroendocrine Tumors(PitNETs)].
Nagamine T; Fukuda I
No Shinkei Geka; 2023 Jul; 51(4):706-715. PubMed ID: 37491068
[TBL] [Abstract][Full Text] [Related]
10. Neuronostatin exerts actions on pituitary that are unique from its sibling peptide somatostatin.
Luque RM; Kineman RD
J Endocrinol; 2018 Jun; 237(3):217-227. PubMed ID: 29615476
[TBL] [Abstract][Full Text] [Related]
11. Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer.
Jiménez-Vacas JM; Herrero-Aguayo V; Montero-Hidalgo AJ; Sáez-Martínez P; Gómez-Gómez E; León-González AJ; Fuentes-Fayos AC; Yubero-Serrano EM; Requena-Tapia MJ; López M; Castaño JP; Gahete MD; Luque RM
J Clin Endocrinol Metab; 2021 Jan; 106(2):e696-e710. PubMed ID: 33247590
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
[TBL] [Abstract][Full Text] [Related]
13. DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells.
Mangili F; Esposito E; Treppiedi D; Catalano R; Marra G; Di Muro G; Barbieri AM; Locatelli M; Lania AG; Mangone A; Spada A; Arosio M; Peverelli E; Mantovani G
Front Endocrinol (Lausanne); 2022; 13():867822. PubMed ID: 35721701
[TBL] [Abstract][Full Text] [Related]
14. A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A Phosphorylation.
Mangili F; Treppiedi D; Catalano R; Marra G; Di Muro G; Spada A; Arosio M; Peverelli E; Mantovani G
Front Endocrinol (Lausanne); 2020; 11():611752. PubMed ID: 33664708
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells.
An J; Pei X; Zang Z; Zhou Z; Hu J; Zheng X; Zhang Y; He J; Duan L; Shen R; Zhang W; Zhu F; Li S; Yang H
Oncotarget; 2017 Jun; 8(23):37538-37549. PubMed ID: 28380462
[TBL] [Abstract][Full Text] [Related]
16. Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence.
Fuentes-Fayos AC; G-García ME; Pérez-Gómez JM; Montero-Hidalgo AJ; Martín-Colom J; Doval-Rosa C; Blanco-Acevedo C; Torres E; Toledano-Delgado Á; Sánchez-Sánchez R; Peralbo-Santaella E; Ortega-Salas RM; Jiménez-Vacas JM; Tena-Sempere M; López M; Castaño JP; Gahete MD; Solivera J; Luque RM
EBioMedicine; 2023 Apr; 90():104484. PubMed ID: 36907105
[TBL] [Abstract][Full Text] [Related]
17. BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas.
Ibáñez-Costa A; López-Sánchez LM; Gahete MD; Rivero-Cortés E; Vázquez-Borrego MC; Gálvez MA; de la Riva A; Venegas-Moreno E; Jiménez-Reina L; Moreno-Carazo A; Tinahones FJ; Maraver-Selfa S; Japón MA; García-Arnés JA; Soto-Moreno A; Webb SM; Kineman RD; Culler MD; Castaño JP; Luque RM
Sci Rep; 2017 Feb; 7():42002. PubMed ID: 28181484
[TBL] [Abstract][Full Text] [Related]
18. Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on AKT Phosphorylation and Cell Proliferation in Pituitary Tumors.
Mangili F; Giardino E; Treppiedi D; Barbieri AM; Catalano R; Locatelli M; Lania AG; Spada A; Arosio M; Mantovani G; Peverelli E
Neuroendocrinology; 2021; 111(6):568-579. PubMed ID: 32512568
[TBL] [Abstract][Full Text] [Related]
19. Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Awad S; Dorward N; Grieve J; Mendoza N; Muquit S; Grossman AB; Balkwill F; Korbonits M
Acta Neuropathol Commun; 2019 Nov; 7(1):172. PubMed ID: 31703742
[TBL] [Abstract][Full Text] [Related]
20. SDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth
Wang X; Fang Y; Zhou Y; Guo X; Xu K; Li C; Zhang J; Hong Y
Front Endocrinol (Lausanne); 2020; 11():566761. PubMed ID: 33362712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
